Year To Quarter End Statement Of Income

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7572450

Concept 2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
Year to quarter end statement of income
Statement of income
Net sales
779,194,000,000 JPY
678,591,000,000 JPY
Cost of sales
268,868,000,000 JPY
263,464,000,000 JPY
Gross profit (loss)
510,326,000,000 JPY
415,127,000,000 JPY
Selling, general and administrative expenses
222,217,000,000 JPY
211,205,000,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
288,109,000,000 JPY
203,921,000,000 JPY
Non-operating income
Non-operating income
5,109,000,000 JPY
5,455,000,000 JPY
Non-operating expenses
Interest expenses
3,000,000 JPY
3,000,000 JPY
Non-operating expenses
2,395,000,000 JPY
1,081,000,000 JPY
Ordinary profit (loss)
290,823,000,000 JPY
208,296,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
3,000,000 JPY
25,000,000 JPY
Extraordinary income
6,000,000 JPY
5,918,000,000 JPY
Extraordinary losses
Loss on sale of non-current assets
1,000,000 JPY
12,000,000 JPY
Impairment losses
275,000,000 JPY
JPY
Extraordinary losses
2,364,000,000 JPY
10,866,000,000 JPY
Profit (loss) before income taxes
288,465,000,000 JPY
203,347,000,000 JPY
Income taxes - current
86,644,000,000 JPY
53,184,000,000 JPY
Income taxes - deferred
-5,974,000,000 JPY
-5,421,000,000 JPY
Income taxes
80,671,000,000 JPY
47,763,000,000 JPY
Profit (loss)
207,795,000,000 JPY
207,795,000,000 JPY
207,795,000,000 JPY
207,795,000,000 JPY
155,584,000,000 JPY
155,584,000,000 JPY
155,584,000,000 JPY
155,584,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.